50 Participants Needed

Autologous Blood Membrane Technique for Gum Recession

DL
TS
AJ
Overseen ByAnn-Marie Jacobson
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Tufts University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

To correct gum recession, patient's own tissue from the roof of the mouth is harvested and placed where there is root exposed. This is considered gold standard of treatment. Sometimes patient don't want to have second surgical site in their mouth and at the same time do not want to use alternative tissue from human or animal donor. Using patients' blood and preparing it as a membrane is the next best thing to correct gum recession.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the Autologous Blood Membrane Technique for treating gum recession?

Research shows that using autologous blood products, which contain healing components like platelets and growth factors, can help improve the healing and regeneration of gum tissue. These products are used alongside traditional gum grafting techniques to enhance outcomes, such as better root coverage and improved tissue quality.12345

Is the Autologous Blood Membrane Technique for Gum Recession safe?

Soft tissue grafts, including those used for gum recession, are generally considered safe with few minor complications. A rare complication, like an unusual wound healing, can occur but is typically manageable with further treatment.678910

How does the Autologous Blood Membrane Technique for Gum Recession differ from other treatments?

The Autologous Blood Membrane Technique is unique because it uses the patient's own blood to create a membrane that aids in healing gum recession, potentially offering a more natural and regenerative approach compared to traditional grafting methods that use donor tissue or synthetic materials.910111213

Research Team

TS

Tannaz Shapurian, DMD, MSc

Principal Investigator

Tufts University School of Dental Medicine

Eligibility Criteria

This trial is for adults over 18 who need treatment for gum recession at two or more sites but don't want a second surgical site or donor tissue. Smokers, pregnant individuals, those not consenting to recommended therapy, and anyone unable to follow up are excluded.

Inclusion Criteria

I am 18 years old or older.
No class V restoration present
I need gum treatment for root coverage at 2 or more sites.
See 1 more

Exclusion Criteria

Patients who will not be able to comply with follow-up protocols
Patients who do not consent to recommended therapy
Patients who smoke
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive CTG procedure on one side and PRF procedure on the other to correct gum recession

12 visits over 5 years
12 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment using intraoral scanner to establish volume stability

5 years

Treatment Details

Interventions

  • Soft Tissue Grafting
Trial OverviewThe study tests the use of patients' own blood prepared as a membrane versus traditional grafting from the roof of the mouth for treating gum recession. It's a split-mouth design, meaning each patient receives both treatments in different areas.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment1 Intervention
Participants will receive the CTG procedure on one side and the PRF procedure on the other. Both are standard of care soft tissue grafting methods and a split mouth design is standard of care.

Soft Tissue Grafting is already approved in United States, European Union, Canada for the following indications:

🇺🇸
Approved in United States as Soft Tissue Grafting for:
  • Gum recession
  • Periodontal defects
  • Oral soft tissue augmentation
🇪🇺
Approved in European Union as Soft Tissue Grafting for:
  • Gum recession
  • Periodontal defects
  • Oral soft tissue augmentation
🇨🇦
Approved in Canada as Soft Tissue Grafting for:
  • Gum recession
  • Periodontal defects
  • Oral soft tissue augmentation

Find a Clinic Near You

Who Is Running the Clinical Trial?

Tufts University

Lead Sponsor

Trials
271
Recruited
595,000+

Findings from Research

The use of autologous blood products (ABPs) in mucogingival surgery showed no adverse events and led to satisfactory treatment outcomes, suggesting they are safe and effective adjuncts to traditional grafting procedures.
ABPs may particularly benefit patients with local or systemic complications, enhancing the predictability of clinical and esthetic results in mucogingival treatments.
Clinical applications of mucogingival therapies utilizing adjunctive autologous blood products.Geisinger, ML., Kaur, M., Abou Arraj, RV., et al.[2023]
In a study involving 14 patients with 20 cases of gingival recession, both acellular dermal matrix allograft (ADMA) and subepithelial connective tissue graft (SCTG) showed significant improvements in recession height, recession width, and keratinized gingiva after six months, indicating their effectiveness in treating gingival recession.
The results demonstrated that ADMA is a viable alternative to SCTG, as both techniques produced similar outcomes in root coverage and other clinical parameters, suggesting that ADMA can be used without compromising treatment efficacy.
Comparative clinical evaluation of acellular dermal matrix allograft and connective tissue graft for the treatment of gingival recession.Rahmani, ME., Lades, MA.[2022]
Mucogingival plastic surgery aims to achieve complete root coverage and aesthetic blending of treated and untreated tissues, addressing the growing demand for cosmetic dental procedures.
While the connective tissue graft is often seen as the best option for treating gingival recession, the choice of surgical technique should be based on a careful evaluation of individual patient and defect characteristics, as all root coverage methods can be effective under real-world conditions.
Decision Making in Gingival Recession Treatment: Scientific Evidence and Clinical Experience.Rasperini, G., Acunzo, R., Limiroli, E.[2020]

References

Clinical applications of mucogingival therapies utilizing adjunctive autologous blood products. [2023]
Comparative clinical evaluation of acellular dermal matrix allograft and connective tissue graft for the treatment of gingival recession. [2022]
Decision Making in Gingival Recession Treatment: Scientific Evidence and Clinical Experience. [2020]
Minimally Invasive Coronally Advanced Flap Techniques for Correction of Gingival Recession Defects: A Review. [2023]
Tunnel technique with connective tissue graft versus coronally advanced flap with enamel matrix derivate for root coverage: 5-year results of an RCT using 3D digital measurement technology for volumetric comparison of soft tissue changes. [2021]
Bacterial cellulose matrix and acellular dermal matrix seeded with fibroblasts grown in platelet-rich plasma supplemented medium, compared to free gingival grafts: a randomized animal study. [2023]
Gingival recession treatment using a bilayer collagen membrane. [2006]
Unusual wound healing following removal of donor tissue for soft tissue graft. [2004]
Treatment of Labial Soft Tissue Recession Around Dental Implants in the Esthetic Zone Using Guided Bone Regeneration With Mineralized Allograft: A Retrospective Clinical Case Series. [2022]
[Soft tissue grafts for the treatment of mucogingival deformities and conditions on edentulous ridges]. [2015]
11.United Statespubmed.ncbi.nlm.nih.gov
Treatment of gingival recession with collagen membranes. [2006]
12.United Statespubmed.ncbi.nlm.nih.gov
Regenerative Treatment for Recession Defects Using Purified Human Platelet-Derived Growth Factor-BB, Particulate Grafts, and Coronally Repositioned Flaps. [2020]
[Therapeutic efficacy of guided tissue regeneration and connective tissue autotransplants with periosteum in the management of gingival recession]. [2019]